We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Corgenix Enters Contract Manufacturing Agreement with Medical Device Company

By LabMedica International staff writers
Posted on 21 Jul 2013
Corgenix Medical Corporation (Denver, CO, USA) has entered into a 10 year contract manufacturing agreement with EDP Biotech (EDP; Denver South, CO, USA), a medical device company. More...
Under terms of the agreement, Corgenix will manufacture and supply the ColoMarker diagnostic test, a blood test developed to detect early stages of colon cancer.

ColoMarker combines diagnostic applications with use as a patient management tool that could help physicians determine the effectiveness of colon cancer treatment in patients. It is a simple blood test designed to identify potential cases of early stage colon cancer. The test requires no advance preparation by the patient such as fasting or colon cleansing and it can be added easily to the panel of blood tests routinely performed at a patient’s annual physical examination.

“We are pleased to enter into this mutually beneficial relationship with EDP,” said Douglass Simpson, president and CEO of Corgenix. “This reflects our strategic focus on the Contract Services portion of our business for diagnostic products, and it meets the increasing overall demand for contract services in the medical device and biotechnology industries.”

Corgenix develops and manufactures specialized diagnostic kits for immunology disorders, vascular diseases, and bone and joint disorders, including a non-blood-based test for aspirin effect. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has experience in product submissions to the US Food and Drug Administration (FDA; Silver Spring, MD, USA) and other worldwide regulatory authorities.

EDP Biotech (EDP) is a medical device company, which develops and commercializes human immunodiagnostic tests. EDP has identified and purified proteins present in the early stages of biological changes for production of in vitro diagnostics tests, whose primary target is the development of early detection products.

Related Links:

Corgenix Medical Corporation
EDP Biotech
FDA



Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Specimen Radiography System
TrueView 200 Pro
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.